Abstracts of the XI Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 11)

The Spanish Group for Cancer Immuno-Biotherapies (GÉTICA) held the XI Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 11) from 13 to 15 March 2025, in Madrid (Spain). FITCancer is the largest meeting uniquely focused on cancer immunotherapy in Spain and brings together clinicians and researchers with expertise in the field of cancer immunology and immunotherapy. Here, we present abstracts submitted by GÉTICA’s members to the XI Forum on Translational Immunology and Cancer Immunotherapy, which were divided into the following three topics: novel therapeutic targets and strategies, cell-based immunotherapies, and clinical scenarios and potential biomarkers.

Authors

Institutions

Publication Details

Published
2025-09-09
DOI
https://doi.org/10.3390/msf2025036002
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstracts of the XI Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 11)

Ana Arance, Xabier Mielgo-Rubio, Luis de la Cruz‐Merino, Luis Álvarez‐Vallina et al.
Immunotherapy and Immune Responses
article

Abstracts of the XI Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 11)

Ana Arance, Xabier Mielgo-Rubio, Luis de la Cruz‐Merino, Luis Álvarez‐Vallina, Rodolfo Chicas-Sett, Delvys Rodríguez‐Abreu, Manel Juan, Elísabeth Pérez-Ruiz, Francisco Aya
article en

Abstract

The Spanish Group for Cancer Immuno-Biotherapies (GÉTICA) held the XI Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 11) from 13 to 15 March 2025, in Madrid (Spain). FITCancer is the largest meeting uniquely focused on cancer immunotherapy in Spain and brings together clinicians and researchers with expertise in the field of cancer immunology and immunotherapy. Here, we present abstracts submitted by GÉTICA’s members to the XI Forum on Translational Immunology and Cancer Immunotherapy, which were divided into the following three topics: novel therapeutic targets and strategies, cell-based immunotherapies, and clinical scenarios and potential biomarkers.

Hospital Universitario Insular de Gran Canaria (ES), Hospital Universitari i Politècnic La Fe (ES), Hospital Universitario Virgen Macarena (ES), Hospital Universitario Fundación Alcorcón (ES), Hospital Universitario 12 De Octubre (ES), Hospital Clínic de Barcelona (ES), Spanish Ovarian Cancer Research Group (ES), GEICAM – Spanish Breast Cancer Group (ES), Instituto de Investigación Biomédica de Málaga (ES)
Gobierno de Navarra
Openalex Percentile: Top 74%
Immunotherapy and Immune Responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.